Determining cytotoxicity (being toxic to cells) is a critical component of identifying compound viability early in the preclinical phase of drug development or new product discovery. Cytotoxicity Screens (measuring cell death or cell viability) are used to give researchers key insight into potential adverse effects due to cell death prior to entering more costly in vivo studies.